Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Daidone

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|June 10, 2015
miR-30e* is an independent subtype-specific prognostic marker in breast cancerF D'Aiuto, M Callari, M Dugo, et al.
International Journal of Cancer|November 24, 1999
Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancerM G Daidone, S Veneroni, E Benini, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapiesG Ranieri, C D Gadaleta, R Patruno, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cellsN Zaffaroni, S Lualdi, R Villa, et al.
Cellular and Molecular Life Sciences : CMLS|October 5, 2002
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancerN Zaffaroni, M Pennati, G Colella, et al.
British Journal of Cancer|March 10, 2001
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancerA Paradiso, G Simone, M D Lena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapyR Silvestrini, M G Daidone, M Mastore, et al.
Breast Cancer Research and Treatment|January 1, 1993
Quantitative immunohistochemical determination of cathepsin-D and its relation with other variablesS Veneroni, M G Daidone, G Di Fronzo, et al.
Journal of the National Cancer Institute|April 6, 1994
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patientsR Silvestrini, S Veneroni, M G Daidone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancerR Silvestrini, M G Daidone, A Luisi, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|June 10, 2015
miR-30e* is an independent subtype-specific prognostic marker in breast cancerF D'Aiuto, M Callari, M Dugo, et al.
International Journal of Cancer|November 24, 1999
Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancerM G Daidone, S Veneroni, E Benini, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapiesG Ranieri, C D Gadaleta, R Patruno, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cellsN Zaffaroni, S Lualdi, R Villa, et al.
Cellular and Molecular Life Sciences : CMLS|October 5, 2002
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancerN Zaffaroni, M Pennati, G Colella, et al.
British Journal of Cancer|March 10, 2001
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancerA Paradiso, G Simone, M D Lena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapyR Silvestrini, M G Daidone, M Mastore, et al.
Breast Cancer Research and Treatment|January 1, 1993
Quantitative immunohistochemical determination of cathepsin-D and its relation with other variablesS Veneroni, M G Daidone, G Di Fronzo, et al.
Journal of the National Cancer Institute|April 6, 1994
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patientsR Silvestrini, S Veneroni, M G Daidone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancerR Silvestrini, M G Daidone, A Luisi, et al.
Pageof 11